FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Michel Azorin

Research Profile

Disorders

Concepts & Ideas

Activities & Behaviors

Schizophrenic Psychology

Geographic Areas

Chemicals & Drugs

Physiology

Temperament

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Jean-Michel Azorin; Laurent Baraille; Jordan Bertsch; Stéphanie Gérard; Catherine Reed; Michael Lukasiewicz
Mixed states with predominant manic or depressive symptoms: baseline characteristics and 24-month outcomes of the EMBLEM cohort.
Michael Lukasiewicz; Elena Perrin; Catherine Reed; Helene Sapin; Mauricio Tohen; Jean-Michel Azorin; Adeline Besnard; Bruno Falissard; Stephanie Gerard
Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort.
Fernando Cañas; Vincent Dubois; Robin Emsley; Antonio G García; Philip Gorwood; Peter M Haddad; Dieter Naber; José M Olivares; Georgios Papageorgiou; Koksal Alptekin; Jean-Michel Azorin; Miquel Roca
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Michel Azorin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jean-Michel Azorin; Laurent Baraille; Jordan Bertsch; Stéphanie Gérard; Catherine Reed; Michael Lukasiewicz
Mixed states with predominant manic or depressive symptoms: baseline characteristics and 24-month outcomes of the EMBLEM cohort.
Journal of affective disorders 2013;146(3):369-77.
2013: Michael Lukasiewicz; Elena Perrin; Catherine Reed; Helene Sapin; Mauricio Tohen; Jean-Michel Azorin; Adeline Besnard; Bruno Falissard; Stephanie Gerard
Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort.
International journal of methods in psychiatric research 2013;22(1):46-58.
2013: Fernando Cañas; Vincent Dubois; Robin Emsley; Antonio G García; Philip Gorwood; Peter M Haddad; Dieter Naber; José M Olivares; Georgios Papageorgiou; Koksal Alptekin; Jean-Michel Azorin; Miquel Roca
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
Clinical drug investigation 2013;33(2):97-107.
2013: Giulio Perugi; Eduard Vieta; Allan H Young; Jules Angst; Jean-Michel Azorin; Charles Bowden
Is comorbid borderline personality disorder in patients with major depressive episode and bipolarity a developmental subtype? Findings from the international BRIDGE study.
Journal of affective disorders 2013;144(1-2):72-8.
2013: José Manuel Olivares; George Papageorgiou; Miquel Roca; Pierre Thomas; Köksal Alptekin; Jean-Michel Azorin; Fernando Cañas; Vincent Dubois; Robin Emsley; Philip Gorwood; Peter M Haddad; Guadalupe Martinez; Dieter Naber; Andreas Schreiner
Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.
Patient preference and adherence 2013;7():121-32.
2012: Jean-Michel Azorin; Raoul Belzeaux; Eric Fakra; Elie G Hantouche; Arthur Kaladjian; Marc Adida; Sylvie Lancrenon
Self-assessment and characteristics of mixed depression in the French national EPIDEP study.
Journal of affective disorders 2012;143(1-3):109-17.
2012: Eduard Vieta; Jean-Michel Azorin; Michael Bauer; Sophia Frangou; Guadalupe Martinez; Giulio Perugi; Andreas Schreiner
Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries.
Journal of affective disorders 2012;143(1-3):125-30.
2012: Jean-Michel Azorin
[Bipolar disorder: inter-episode symptoms].
L'Encéphale 2012;38 Suppl 4():S147-50.
2012: M Adida; Jean-Michel Azorin; R Belzeaux; Eric Fakra; Arthur Kaladjian; P Pomietto; N Corréard
[Schizophrenia and/or bipolar disorder: neurobiological endophenotypes].
L'Encéphale 2012;38 Suppl 3():S98-102.
2012: Eric Fakra; Arthur Kaladjian; P Mazzola; M Adida; R Belzeaux; M Cermolacce; N Corréard; M Dubois; Jean-Michel Azorin
[Emotion endophenotypes in bipolar and schizophrenic disorders].
L'Encéphale 2012;38 Suppl 3():S93-7.
2012: M Dubois; Eric Fakra; M Adida; Jean-Michel Azorin; R Belzeaux
[Emotional endophenotypes and bipolar disorder].
L'Encéphale 2012;38 Suppl 3():S85-92.
2012: Arthur Kaladjian; P Pomietto; Jean-Michel Azorin; R Belzeaux; N Corréard; M Adida
[Schizophrenia and/or bipolar disorder: the neurocognitive endophenotypes].
L'Encéphale 2012;38 Suppl 3():S81-4.
2012: Pascale Mazzola-Pomietto; M Adida; Jean-Michel Azorin; R Belzeaux; Eric Fakra; Arthur Kaladjian
[Are variations of structural neuro-anatomy promising endophenotype candidates in bipolar disorder?].
L'Encéphale 2012;38 Suppl 3():S75-80.
2012: Jean-Michel Azorin; R Belzeaux; M Cermolacce; N Corréard; M Dubois; Eric Fakra; P Mazzola; Dominique Pringuey; M Sokolowsky; M Adida; Arthur Kaladjian
[Temperamental endophenotypes].
L'Encéphale 2012;38 Suppl 3():S70-4.
2012: M Sokolowsky; Eric Fakra; Jean-Michel Azorin
[Endophenotypes and autism spectrum disorders].
L'Encéphale 2012;38 Suppl 3():S67-9.
2012: Jean-Michel Azorin
[Schizophrenia and/or bipolar disorder: which endophenotypes?].
L'Encéphale 2012;38 Suppl 3():S55-6.
2012: Dominique Pringuey; F Cherikh; C Clad; Eric Fakra; B Giordana; F Jover; Frantz-Samy Kohl; Jean-Michel Azorin
[Endophenotypes of the biorhythms and the sleep in depression].
L'Encéphale 2012;38 Suppl 3():S116-20.
2012: N Correard; S N Elissalde; Eric Fakra; Jean-Michel Azorin; R Belzeaux
[Psychotherapeutic and psychosocial interventions and endophenotypes in bipolar disorders].
L'Encéphale 2012;38 Suppl 3():S110-5.
2012: Jean-Pierre Schuster; Delphine Raucher-Chéné; Frédéric Rouillon; Jean-Michel Azorin; Isabelle Gasquet; Fabien Gierski; Denis Leguay; Cédric Lemogne; Frédéric Limosin
Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia.
Journal of clinical psychopharmacology 2012;32(5):672-7.
2012: Carrà Giuseppe; Dirk Heider; Sonia Johnson; Matthias C Angermeyer; Jean-Michel Azorin; Paul Bebbington; Traolach Brugha; Mondher Toumi
The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).
European archives of psychiatry and clinical neuroscience 2012;262(7):607-16.
2012: Eric Fakra; Jean-Michel Azorin
Clozapine for the treatment of schizophrenia.
Expert opinion on pharmacotherapy 2012;13(13):1923-35.
2012: OUZIR Mounir; Driss Boussaoud; Marc Adida; Jean-Michel Azorin; Omar Battas
Insight in schizophrenia: from conceptualization to neuroscience.
Psychiatry and clinical neurosciences 2012;66(3):167-79.
2012: Jean-Michel Azorin; Marc Adida; Arthur Kaladjian; Eric Fakra
Late-onset bipolar illness: the geriatric bipolar type VI.
CNS neuroscience & therapeutics 2012;18(3):208-13.
2012: Jean-Michel Azorin; Charles L Bowden; Alex Gamma; Giulio Perugi; Eduard Vieta; Jules Angst; Allan Young
Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study.
Journal of affective disorders 2012;136(3):710-5.
2012: Emmanuelle Sarlon; Samuel Aballéa; Matthias C Angermeyer; Jean-Michel Azorin; Karina Hansen; Dirk Heider; Hans-Helmut König; Aurélie Millier; Mondher Toumi
A prospective study of health care resource utilisation and selected costs of schizophrenia in France.
BMC health services research 2012;12():269-76.
2011: Marc Adida; Jean-Michel Azorin; Nathalie Besnier; Luke Clark; Guy M Goodwin; Sébastien Guillaume; Régine Jeanningros; Fabrice Jollant; Arthur Kaladjian; Pascale Mazzola-Pomietto; Philippe Courtet
Trait-related decision-making impairment in the three phases of bipolar disorder.
Biological psychiatry 2011;70(4):357-65.
2011: Jules Angst; Jean-Michel Azorin; Charles L Bowden; Alex Gamma; Giulio Perugi; Eduard Vieta; Allan H Young
Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
Archives of general psychiatry 2011;68(8):791-8.
2011: Frank Bellivier; Jordan Bertsch; Stephanie Gerard; Amandine Luquiens; Catherine Reed; Liova Yon; Jean-Michel Azorin; Michael Lukasiewicz
Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM).
Bipolar disorders 2011;13(4):377-86.
2011: Jean-Michel Azorin; Arthur Kaladjian; Marc Adida; Eric Fakra; Elie G Hantouche; Sylvie Lancrenon
Correlates of first-episode polarity in a French cohort of 1089 bipolar I disorder patients: role of temperaments and triggering events.
Journal of affective disorders 2011;129(1-3):39-46.
2011: Arthur Kaladjian; Régine Jeanningros; Jean-Michel Azorin; Jean-Luc Anton; Pascale Mazzola-Pomietto
Impulsivity and neural correlates of response inhibition in schizophrenia.
Psychological medicine 2011;41(2):291-9.
2011: Aurelie Millier; Emmanuelle Sarlon; Jean-Michel Azorin; Laurent Boyer; Samuel Aballea; Pascal Auquier; Mondher Toumi
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis.
BMC psychiatry 2011;11():24.
2011: Nathalie Besnier; Arthur Kaladjian; Pascale Mazzola-Pomietto; Marc Adida; Eric Fakra; Régine Jeanningros; Jean-Michel Azorin
Differential responses to emotional interference in paranoid schizophrenia and bipolar mania.
Psychopathology 2011;44(1):1-11.
2010: M Maurel; Jean-Michel Azorin; M Adida; Eric Fakra; R Richieri; T Bottai; Dominique Pringuey; Arthur Kaladjian
[Bipolar affective disorders: Models and assessment of psychological treatments].
L'Encéphale 2010;36 Suppl 6():S202-5.
2010: R Richieri; M Adida; R Dumas; Eric Fakra; Jean-Michel Azorin; Dominique Pringuey; C Lancon
[Affective disorders and repetitive transcranial magnetic stimulation: Therapeutic innovations].
L'Encéphale 2010;36 Suppl 6():S197-201.
2010: M Adida; R Richieri; M Maurel; Arthur Kaladjian; David Da Fonseca; T Bottai; Eric Fakra; Dominique Pringuey; Jean-Michel Azorin
[Affective disorders, antipsychotics and mood stabilizers: Therapeutic innovations].
L'Encéphale 2010;36 Suppl 6():S188-96.
2010: Eric Fakra; Jean-Michel Azorin; M Adida; David Da Fonseca; Arthur Kaladjian; Dominique Pringuey
[Affective disorders and antidepressant drugs: Therapeutic innovations].
L'Encéphale 2010;36 Suppl 6():S183-7.
2010: Arthur Kaladjian; Jean-Michel Azorin; M Adida; Eric Fakra; David Da Fonseca; Dominique Pringuey
[Affective disorders: Evolution of nosographic models].
L'Encéphale 2010;36 Suppl 6():S178-82.
2010: David Da Fonseca; F Bat; N Rouviere; S Campredon; D Bastard-Rosset; M Viellard; A Santos; C Deruelle; Jean-Michel Azorin; Eric Fakra; M Adida
[Bipolar disorder: Continuity from child to adult?].
L'Encéphale 2010;36 Suppl 6():S173-7.
2010: Jean-Michel Azorin; Arthur Kaladjian; Eric Fakra; David Da Fonseca; M Adida; M Maurel; R Richieri; T Bottai; Dominique Pringuey
[Gene-environment interactions in affective disorders].
L'Encéphale 2010;36 Suppl 6():S167-72.
2010: Dominique Pringuey; Eric Fakra; F Cherikh; T Bottaï; O Tible; M Maurel; R Richieri; M Adida; Arthur Kaladjian; Jean-Michel Azorin
[Affective disorders: News in chronobiological models].
L'Encéphale 2010;36 Suppl 6():S157-66.
2010: Jean-Michel Azorin; Arthur Kaladjian; Eric Fakra; Marc Adida
Sertindole for the treatment of schizophrenia.
Expert opinion on pharmacotherapy 2010;11(18):3053-64.
2010: Jean-Michel Azorin; Arthur Kaladjian; N Besnier; M Adida; Elie G Hantouche; Sylvie Lancrenon; H Akiskal
Suicidal behaviour in a French Cohort of major depressive patients: characteristics of attempters and nonattempters.
Journal of affective disorders 2010;123(1-3):87-94.
2010: Jean-Michel Azorin; Charles L Bowden; Ricardo P Garay; Giulio Perugi; Eduard Vieta; Allan H Young
Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism.
Neuropsychiatric disease and treatment 2010;6():37-46.
2010: Eric Fakra; Arthur Kaladjian; David Da Fonseca; M Maurel; M Adida; N Besnier; D Pringuey; Jean-Michel Azorin
[Prodromal phase in bipolar disorder].
L'Encéphale 2010;36 Suppl 1():S8-12.
2010: M Maurel; Arthur Kaladjian; Eric Fakra; N Besnier; M Adida; Jean-Michel Azorin
[Treatment of a first manic episode].
L'Encéphale 2010;36 Suppl 1():S23-6.
2010: N Besnier; Eric Fakra; Arthur Kaladjian; M Adida; M Maurel; Jean-Michel Azorin
[Depressive onset episode of bipolar disorder: clinical and prognostic considerations].
L'Encéphale 2010;36 Suppl 1():S18-22.
2010: Arthur Kaladjian; Eric Fakra; M Adida; N Besnier; M Maurel; Jean-Michel Azorin
[Manic polarity of the onset episode of bipolar disorder: clinical and prognostic considerations].
L'Encéphale 2010;36 Suppl 1():S13-7.
2009: Steven Marwaha; Sonia Johnson; Paul E Bebbington; Matthias C Angermeyer; Traolach S Brugha; Jean-Michel Azorin; Reinhold Killian; Karina Hansen; Mondher Toumi
Predictors of employment status change over 2 years in people with schizophrenia living in Europe.
Epidemiologia e psichiatria sociale 2009;18(4):344-51.
2009: Jean-Michel Azorin; Arthur Kaladjian
[The affective schizophrenia concept].
L'Encéphale 2009;35 Suppl 5():S151-4.
2009: Arthur Kaladjian; Régine Jeanningros; Jean-Michel Azorin; Bruno Nazarian; Muriel Roth; Jean-Luc Anton; Pascale Mazzola-Pomietto
Remission from mania is associated with a decrease in amygdala activation during motor response inhibition.
Bipolar disorders 2009;11(5):530-8.
2009: Arthur Kaladjian; Régine Jeanningros; Jean-Michel Azorin; Bruno Nazarian; Muriel Roth; Pascale Mazzola-Pomietto
Reduced brain activation in euthymic bipolar patients during response inhibition: an event-related fMRI study.
Psychiatry research 2009;173(1):45-51.
2009: Jean-Michel Azorin; Arthur Kaladjian; Marc Adida; Elie G Hantouche; Ahcene Hameg; Sylvie Lancrenon; Hagop Souren Akiskal
Risk factors associated with lifetime suicide attempts in bipolar I patients: findings from a French National Cohort.
Comprehensive psychiatry 2009;50(2):115-20.
2009: Jean-Michel Azorin; Arthur Kaladjian
An update on the treatment of bipolar depression.
Expert opinion on pharmacotherapy 2009;10(2):161-72.
2009: Jean-Michel Azorin; Arthur Kaladjian; Marc Adida; Elie G Hantouche; Ahcene Hameg; Sylvie Lancrenon; Hagop S Akiskal
Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort.
Psychopathology 2009;42(6):380-6.
2009: Nathalie Besnier; Floriane Richard; Xavier Zendjidjian; Arthur Kaladjian; Pascale Mazzola-Pomietto; Marc Adida; Jean-Michel Azorin
Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders: distinct markers of vulnerability?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):809-18.
2009: Jean-Michel Azorin; A Kaladjian
[Depression and circadian rhythm].
L'Encéphale 2009;35 Suppl 2():S68-71.
2009: Pascale Mazzola-Pomietto; Arthur Kaladjian; Jean-Michel Azorin; Jean-Luc Anton; Régine Jeanningros
Bilateral decrease in ventrolateral prefrontal cortex activation during motor response inhibition in mania.
Journal of psychiatric research 2009;43(4):432-41.
2009: Eric Fakra; Pilar Salgado-Pineda; Nathalie Besnier; Jean-Michel Azorin; Olivier Blin
Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):719-28.
2008: Jean-Michel Azorin; Arthur Kaladjian; Marc Adida; Elie G Hantouche; Ahcene Hameg; Sylvie Lancrenon; Hagop Souren Akiskal
Toward the delineation of mania subtypes in the French National EPIMAN-II Mille Cohort. Comparisons with prior cluster analytic investigations.
European archives of psychiatry and clinical neuroscience 2008;258(8):497-504.
2008: Marc Adida; Luke Clark; Pascale Pomietto; Arthur Kaladjian; Nathalie Besnier; Jean-Michel Azorin; Régine Jeanningros; Guy M Goodwin
Lack of insight may predict impaired decision making in manic patients.
Bipolar disorders 2008;10(7):829-37.
2008: Eric Fakra; S Khalfa; D Da Fonseca; N Besnier; P Delaveau; Jean-Michel Azorin; Olivier Blin
Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients.
Psychopharmacology 2008;200(2):261-72.
2008: Jean-Michel Azorin; Arthur Kaladjian; Marc Adida; Elie G Hantouche; Ahcene Hameg; Sylvie Lancrenon; Hagop S Akiskal
Factors associated with rapid cycling in bipolar I manic patients: findings from a French national study.
CNS spectrums 2008;13(9):780-7.
2008: Jean-Michel Azorin
[From psychotic to bipolar disorders].
L'Encéphale 2008;34 Suppl 4():S127-9.
2008: Jean-Michel Azorin; Arthur Kaladjian; Nathalie Besnier; Michel Cermolacce
[Who is Called "Schizophrenic"?].
Thérapie 2008;63(3):231-5.
2008: Valérian Chambon; Nicolas Franck; Etienne Koechlin; Eric Fakra; Gabriela Ciuperca; Jean-Michel Azorin; Chlöé Farrer
The architecture of cognitive control in schizophrenia.
Brain : a journal of neurology 2008;131(Pt 4):962-70.
2008: Georg Schomerus; Dirk Heider; Matthias C Angermeyer; Paul E Bebbington; Jean-Michel Azorin; Traolach Brugha; Mondher Toumi
Urban residence, victimhood and the appraisal of personal safety in people with schizophrenia: results from the European Schizophrenia Cohort (EuroSC).
Psychological medicine 2008;38(4):591-7.
2008: Nathalie Besnier; Arthur Kaladjian; Pascale Mazzola-Pomietto; Marc Adida; Eric Fakra; Régine Jeanningros; Jean-Michel Azorin
[Selecting material to develop an emotional Stroop test adapted to schizophrenia and bipolar disorders].
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2008;53(3):177-88.
2008: Steven Marwaha; Sonia Johnson; Paul Bebbington; Matthias C Angermeyer; Traolach Brugha; Jean-Michel Azorin; Reinhold Kilian; Asa Kornfeld; Mondher Toumi
Correlates of subjective quality of life in people with schizophrenia: findings from the EuroSC study.
The Journal of nervous and mental disease 2008;196(2):87-94.
2008: Jean-Michel Azorin; Susana Murteira; Karina Hansen; Mondher Toumi
Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.
BMC psychiatry 2008;8():16.
2007: Arthur Kaladjian; Régine Jeanningros; Jean-Michel Azorin; Stephan Grimault; Jean-Luc Anton; Pascale Mazzola-Pomietto
Blunted activation in right ventrolateral prefrontal cortex during motor response inhibition in schizophrenia.
Schizophrenia research 2007;97(1-3):184-93.
2007: Georg Schomerus; Dirk Heider; Matthias C Angermeyer; Paul E Bebbington; Jean-Michel Azorin; Traolach Brugha; Mondher Toumi
Residential area and social contacts in schizophrenia. Results from the European Schizophrenia Cohort (EuroSC).
Social psychiatry and psychiatric epidemiology 2007;42(8):617-22.
2007: Steven Marwaha; Sonia Johnson; Paul Bebbington; Mai Stafford; Matthias C Angermeyer; Traolach Brugha; Jean-Michel Azorin; Reinhold Kilian; Karina Hansen; Mondher Toumi
Rates and correlates of employment in people with schizophrenia in the UK, France and Germany.
The British journal of psychiatry : the journal of mental science 2007;191():30-7.
2007: Joseph Peuskens; nicholas moore; Jean-Michel Azorin; Mondher Toumi; John Cochran
The European sertindole safety and exposure survey: a follow-up study of 8600 patients.
Pharmacoepidemiology and drug safety 2007;16(7):804-11.
2007: Dirk Heider; Matthias C Angermeyer; Ines Winkler; Georg Schomerus; Paul E Bebbington; Traolach Brugha; Jean-Michel Azorin; Mondher Toumi
A prospective study of Quality of life in schizophrenia in three European countries.
Schizophrenia research 2007;93(1-3):194-202.
2007: Christiane Roick; Dirk Heider; Paul E Bebbington; Matthias C Angermeyer; Jean-Michel Azorin; Traolach Brugha; Reinhold Kilian; Sonia Johnson; Mondher Toumi; Asa Kornfeld
Burden on caregivers of people with schizophrenia: comparison between Germany and Britain.
The British journal of psychiatry : the journal of mental science 2007;190():333-8.
2007: Jean-Michel Azorin; Robert L Findling
Valproate use in children and adolescents with bipolar disorder.
CNS drugs 2007;21(12):1019-33.
2007: Jean-Michel Azorin; Arthur Kaladjian; Hagop S Akiskal; Elie G Hantouche; Liliane Châtenet Duchêne; Charles Gury; Sylvie Lancrenon
Validation of a severity threshold for the Mania Rating Scale: a receiver-operating characteristic analysis.
Psychopathology 2007;40(6):453-60.
2007: Jean-Michel Azorin; Hagop S Akiskal; Kareen K Akiskal; Elie G Hantouche; L Châtenet-Duchêne; Charles Gury; Sylvie Lancrenon
Is psychosis in DSM-IV mania due to severity? The relevance of selected demographic and comorbid social-phobic features.
Acta psychiatrica Scandinavica 2007;115(1):29-34.
2006: Elie G Hantouche; Hagop S Akiskal; Jean-Michel Azorin; L Châtenet-Duchêne; Sylvie Lancrenon
Clinical and psychometric characterization of depression in mixed mania: a report from the French National Cohort of 1090 manic patients.
Journal of affective disorders 2006;96(3):225-32.
2006: Jean-Michel Azorin; Hagop S Akiskal; Elie G Hantouche
The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients.
Journal of affective disorders 2006;96(3):215-23.
2006: Arthur Kaladjian; Pascale Mazzola-Pomietto; Régine Jeanningros; Jean-Michel Azorin
[Brain structural abnormalities of bipolar disorder].
L'Encéphale 2006;32(4 Pt 1):421-36.
2006: Jean-Michel Azorin; Nathalie Strub; Henrik Loft
A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
International clinical psychopharmacology 2006;21(1):49-56.
2005: Paul E Bebbington; Matthias C Angermeyer; Jean-Michel Azorin; Traolach Brugha; Reinhold Kilian; Sonia Johnson; Mondher Toumi; Asa Kornfeld
The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study.
Social psychiatry and psychiatric epidemiology 2005;40(9):707-17.
2005: Jean-Michel Azorin; Arthur Kaladjian; E Fakra
[Current issues on schizoaffective disorder].
L'Encéphale 2005;31(3):359-65.
2005: Pierre Chiaroni; Elie G Hantouche; J Gouvernet; Jean-Michel Azorin; H S Akiskal
The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies?
Journal of affective disorders 2005;85(1-2):135-45.
2005: Hagop S Akiskal; Kareen K Akiskal; Jean-François Allilaire; Jean-Michel Azorin; Marc L Bourgeois; Daniel Sechter; Jean-Philippe Fraud; Liliane Chatenêt-Duchêne; Sylvie Lancrenon; Giulio Perugi; Elie G Hantouche
Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study.
Journal of affective disorders 2005;85(1-2):29-36.
2004: Pierre Chiaroni; Elie G Hantouche; J Gouvernet; Jean-Michel Azorin; H S Akiskal
[Hyperthymic and depressive temperaments study in controls, as a function of their familial loading for mood disorders].
L'Encéphale 2004;30(6):509-15.
2003: Jean-Michel Azorin
[Criteria defining antimanic drugs (psychopharmacological specificity and/or nonspecificity?)].
L'Encéphale 2003;29(1):59-67.
2003: Hagop S Akiskal; Elie G Hantouche; Jean-François Allilaire; Daniel Sechter; Marc L Bourgeois; Jean-Michel Azorin; Liliane Chatenêt-Duchêne; Sylvie Lancrenon
Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).
Journal of affective disorders 2003;73(1-2):65-74.
2003: Hagop S Akiskal; Jean-Michel Azorin; Elie G Hantouche
Proposed multidimensional structure of mania: beyond the euphoric-dysphoric dichotomy.
Journal of affective disorders 2003;73(1-2):7-18.
2002: Jean-Michel Azorin; Jean Naudin
Schizophrenia: two-faced meaning of vulnerability.
American journal of medical genetics 2002;114(8):921-2.
2002: Jacques Serratrice; Patrick Disdier; Arthur Kaladjian; Brigitte Granel; Jean-Michel Azorin; René Laugier; Michel Berenguer; Pierre Jean Weiller
[Psychosis revealing a silent celiac disease in a young women with trisomy 21].
Presse médicale (Paris, France : 1983) 2002;31(33):1551-3.
2001: Elie G Hantouche; J P Allilaire; Marc L Bourgeois; Jean-Michel Azorin; Daniel Sechter; Liliane Chatenêt-Duchêne; Sylvie Lancrenon; Hagop S Akiskal
The feasibility of self-assessment of dysphoric mania in the French national EPIMAN study.
Journal of affective disorders 2001;67(1-3):97-103.
2001: Hagop S Akiskal; Elie G Hantouche; Marc L Bourgeois; Jean-Michel Azorin; Daniel Sechter; Jean-François Allilaire; Liliane Chatenêt-Duchêne; Sylvie Lancrenon
Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study.
Journal of affective disorders 2001;67(1-3):89-96.
2001: Jean-François Allilaire; Elie G Hantouche; Daniel Sechter; Marc L Bourgeois; Jean-Michel Azorin; Sylvie Lancrenon; L Châtenet-Duchêne; Hagop S Akiskal
[Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP].
L'Encéphale 2001;27(2):149-58.
2000: Pierre Chiaroni; Jean-Michel Azorin; Daniel Dassa; J M Henry; Sébastien Giudicelli; Y Malthiéry; Richard Planells
Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder.
Psychiatric genetics 2000;10(1):43-9.
2000: Xavier Moreau; Jean-Michel Azorin; P J Lejeune; Régine Jeanningros
Red blood cell triiodothyronine uptake in unipolar major depression: effect of a chronic antidepressant treatment.
Progress in neuro-psychopharmacology & biological psychiatry 2000;24(1):23-35.
1999: F Serres; Jean-Michel Azorin; M Valli; Régine Jeanningros
Evidence for an increase in functional platelet 5-HT2A receptors in depressed patients using the new ligand [125I]-DOI.
European psychiatry : the journal of the Association of European Psychiatrists 1999;14(8):451-7.
1998: Hagop S Akiskal; Elie G Hantouche; Marc L Bourgeois; Jean-Michel Azorin; Daniel Sechter; Jean-François Allilaire; Sylvie Lancrenon; Jean-Philippe Fraud; L Châtenet-Duchêne
Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN).
Journal of affective disorders 1998;50(2-3):175-86.
1998: Elie G Hantouche; Hagop S Akiskal; Sylvie Lancrenon; Jean-François Allilaire; Daniel Sechter; Jean-Michel Azorin; M Bourgeois; Jean-Philippe Fraud; L Châtenet-Duchêne
Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP).
Journal of affective disorders 1998;50(2-3):163-73.
1998: Xavier Moreau; Jean-Michel Azorin; M Maurel; Régine Jeanningros
Increase in red blood cell triiodothyronine uptake in untreated unipolar major depressed patients compared to healthy volunteers.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(2):293-310.
1997: J Naudin; Christian Capo; B Giusano; J L Mège; Jean-Michel Azorin
A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?
Schizophrenia research 1997;26(2-3):227-33.
1997: F Serres; Daniel Dassa; Jean-Michel Azorin; Régine Jeanningros
Red blood cell L-tryptophan uptake in depression. II. Effect of an antidepressant treatment.
Psychiatry research 1997;66(2-3):87-96.
1996: Régine Jeanningros; F Serres; Daniel Dassa; Jean-Michel Azorin; S Grignon
Red blood cell L-tryptophan uptake in depression: kinetic analysis in untreated depressed patients and healthy volunteers.
Psychiatry research 1996;63(2-3):151-9.
1996: J Naudin; J L Mège; Jean-Michel Azorin; Daniel Dassa
Elevated circulating levels of IL-6 in schizophrenia.
Schizophrenia research 1996;20(3):269-73.
1996: Daniel Dassa; Jean-Michel Azorin; V Ledoray; R Sambuc; S Giudicelli
Season of birth and schizophrenia: sex difference.
Progress in neuro-psychopharmacology & biological psychiatry 1996;20(2):243-51.
1995: F Serres; Daniel Dassa; Jean-Michel Azorin; Régine Jeanningros
Decrease in red blood cell L-tryptophan uptake in schizophrenic patients: possible link with loss of impulse control.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(5):903-13.
1995: Daniel Dassa; J Naudin; Jean-Michel Azorin
[New neuroleptic agents and new models for psychoses].
Annales médico-psychologiques 1995;153(2):106-20.
1994: Jean-Michel Azorin; Olivier Blin; P Philippot
[Clinical aspects of depression in the psychotic patient].
L'Encéphale 1994;20 Spec No 4():663-6.
1994: P Mazzola-Pomietto; Jean-Michel Azorin; V Tramoni; Régine Jeanningros
Relation between lymphocyte beta-adrenergic responsivity and the severity of depressive disorders.
Biological psychiatry 1994;35(12):920-5.
1994: Jean-Michel Azorin
[Treatment of depressed dementia or demented depression].
L'Encéphale 1994;20 Spec No 2():281-4.
1994: B Gronier; Jean-Michel Azorin; Daniel Dassa; Régine Jeanningros
Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(1):7-14.
1994: Jean-Michel Azorin; P Bovier; P Chiaroni; H Dufour; J M Gaillard; J Jeanningros; D Pringuey; D Raucoules; C Samuelian-Massat; J Widmer
[7 years study of erythrocyte membrane transport of monoamine precursors. 395 patients (335 depressed, 60 schizophrenic patients)].
L'Encéphale 1994;20(2):111-9.
1993: Daniel Dassa; A Kaladjian; Jean-Michel Azorin; S Giudicelli
Clozapine in the treatment of psychotic refractory depression.
The British journal of psychiatry : the journal of mental science 1993;163():822-4.
1993: Jean-Michel Azorin; A Donnet; Daniel Dassa; D Gambarelli
Creutzfeldt-Jakob disease misdiagnosed as depressive pseudodementia.
Comprehensive psychiatry 1993;34(1):42-4.
1993: B Gronier; Jean-Michel Azorin; Daniel Dassa; Régine Jeanningros
Evidence for a defective platelet L-tryptophan transport in depressed patients.
International clinical psychopharmacology 1993;8(2):87-93.
1992: Jean-Michel Azorin
[Phenomenology in dysthymic disorders].
L'Encéphale 1992;18 Spec No 5():701-2.
1992: D Raucoules; C Levy; Jean-Michel Azorin; M Bruno; M Valli
[Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
L'Encéphale 1992;18(6):611-6.
1992: Jean-Michel Azorin; P Bovier; J Widmer; R Tissot; Régine Jeanningros
[Erythrocyte membrane transport of amino acid precursors of monoamines in schizophrenic patients. Comparison with depressive patients].
L'Encéphale 1992;18(5):585-90.
1992: Jean-Michel Azorin; Daniel Dassa; M Jalfre
[The atypical neuroleptic concept].
L'Encéphale 1992;18 Spec No 3():453-7.
1992: A V Tramoni; H Dufour; Jean-Michel Azorin; A Tatossian
[A 15 years' follow-up of use of lithium at the Department of Psychiatry of Marseille University. Data concerning the follow-up of 205 patients].
L'Encéphale 1992;18 Spec No 1():86-9.
1991: T Bottai; C Levy; C Lancon; Jean-Michel Azorin; S Grignon; M Valli; G Jadot; R Tissot
[Plasma MHPG, peripheral noradrenergic marker and hormonal plasma levels of cortisol-T3-T4-TSH in depressive syndromes].
L'Encéphale 1991;17(3):203-11.
1991: D Raucoules; Jean-Michel Azorin; A Barre; R Tissot
[Plasma levels and membrane transports in red blood cell of tyrosine and tryptophane in depression. Evaluation at baseline and recovery].
L'Encéphale 1991;17(3):197-201.
1991: Régine Jeanningros; P Mazzola; Jean-Michel Azorin; C Samuelian-Massa; R Tissot
Beta-adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders.
Biological psychiatry 1991;29(8):789-98.
1991: Jean-Michel Azorin; C Samuelian-Massat; Régine Jeanningros; J Widmer; R Tissot
[Erythrocyte membrane transports of monoamine precursor amino acids in schizophrenia].
L'Encéphale 1991;17(2):83-6.
1991: A Souche; Pierre Baumann; L Koeb; P Thermoz; Jean-Michel Azorin; H Dufour
[Treatment of depression by a combination of clomipramine and triiodothyronine].
L'Encéphale 1991;17(1):37-42.
1991: P Mazzola; Régine Jeanningros; Jean-Michel Azorin; L Aligne; R Tissot
Early decrease in density of mononuclear leukocyte beta-adrenoceptors in depressed patients following amineptine treatment: possible relation to clinical efficiency.
Progress in neuro-psychopharmacology & biological psychiatry 1991;15(3):357-67.
1990: Jean-Michel Azorin; P Bovier; J Widmer; Régine Jeanningros; R Tissot
L-tyrosine and L-tryptophan membrane transport in erythrocytes and antidepressant drug choice.
Biological psychiatry 1990;27(7):723-34.
1990: Jean-Michel Azorin; G Pupeschi; M Valli; P Joanny; D Raucoules; C Lancon; R Tissot
Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables.
Acta psychiatrica Scandinavica 1990;81(1):14-8.
1990: Jean-Michel Azorin; Anne Donnet; M Habib; H Regis
[Diagnostic criteria of depressive pseudodementia].
L'Encéphale 1990;16(1):31-4.
1990: Jean-Michel Azorin; D Raucoules; M Valli; C Levy; C Lancon; J M Luccioni; R Tissot
Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
Neuropsychobiology 1990;23(1):18-24.
1990: P Chiaroni; Jean-Michel Azorin; P Bovier; J Widmer; Régine Jeanningros; A Barré; H Dufour; A Tatossian; R Tissot
A multivariate analysis of red blood cell membrane transports and plasma levels of L-tyrosine and L-tryptophan in depressed patients before treatment and after clinical improvement.
Neuropsychobiology 1990;23(1):1-7.
1989: O Blin; Jean-Michel Azorin; Y Lecrubier; A Souche; J Fondarai
[The Psychotic Anxiety Scale (PAS). Evaluation of inter-rater reliability and correspondence factorial analysis].
L'Encéphale 1989;15(6):543-7.
1989: Régine Jeanningros; B Gronier; Jean-Michel Azorin; R Tissot
Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
Neuropsychobiology 1989;22(1):33-40.
1988: Jean-Michel Azorin; P Thermoz
[Tardive dyskinesia and affective disorders].
L'Encéphale 1988;14(5):359-63.
1988: A V Tramoni; Jean-Michel Azorin
[Therapeutic indications of S-adenosyl methionine in neuropsychiatry].
L'Encéphale 1988;14(3):113-8.
1988: Jean-Michel Azorin; Félicien Karege; M Valli; D Pringuey; P Joanny; R Tissot
Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients.
Neuropsychobiology 1988;20(2):67-73.
1987: Jean-Michel Azorin; V Tramoni
Kindling models and antikindling effects of mood normalizers.
Pharmacopsychiatry 1987;20(5):189-91.
1987: Félicien Karege; J M Gaillard; R Tissot; Jean-Michel Azorin; M Valli
Determination of 3,4-dihydroxyphenylglycol (DHPG) by HPLC with coulometric detection, and correlation with 3-methoxy-4-hydroxyphenylglycol (MHPG) in human plasma.
Biomedical chromatography : BMC 1987;2(1):30-3.
1986: Jean-Michel Azorin; S Giudicelli; J J Ferrand; J Lieutaud; A Donnet; M J Galea
[Affective disorders, diabetes and carbohydrate metabolism].
L'Encéphale 1986;12(5):279-83.
1986: Jean-Michel Azorin; J C Samuelian; D Pringuey; A Donnet; T Bottai; H Dufour; A Tatossian
[Role of carbamazepine in the treatment of endogenous psychoses. Results of an open study].
L'Encéphale 1986;12(3):115-9.